Cellectis to Present Poster on TALEN-Edited MUC1 CAR T-Cells for Triple Negative Breast Cancer at AACR Annual Meeting
Cellectis, a leading biotechnology company, has recently announced their upcoming poster presentation at the American Association of Cancer Research (AACR) ...